The goal of this clinical trial is to determine the efficacy of Clemastine Fumarate in the presence of engineered sound to treat age-related central auditory processing disorder (CAPD). This disorder impacts 800M patients worldwide, including ~1/3 people over 40 years of age and ~1/2 people over 65, resulting in an inability to hear in noisy environments. The primary hypothesis this study aims...
Is this your first time using hearing aids? We want to learn how they affect your daily life through three short online surveys.
This study plans to learn more about how tinnitus severity (how bothersome or non-bothersome the tinnitus is) affects the brain, and cognition.
We want to see how well over-the-counter (OTC) hearing aids work when fitted in different ways like self-fit, online self-fit, or fit by a hearing healthcare provider, compared to prescription hearing aids.
This study wants to learn more about hearing loss using samples from a child, both of their biological parents, and/or other family members. We will use the samples to study heritable risk factors for hearing loss and changes in gene expression that lead to hearing loss and/or ear abnormalities.
In this study we want to learn how infants hear speech sounds and how that affects their language development.